A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models
- PMID: 25256646
- PMCID: PMC4363129
- DOI: 10.1016/j.jneumeth.2014.09.019
A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models
Abstract
Background: Nonadherence to a physician-prescribed therapeutic intervention is a costly, dangerous, and sometimes fatal concern in healthcare. To date, the study of nonadherence has been constrained to clinical studies. The novel approach described herein allows for the preclinical study of nonadherence in etiologically relevant disease animal model systems.
New method: The method herein describes a novel computer-automated pellet delivery system which allows for the study of nonadherence in animals. This system described herein allows for tight experimenter control of treatment using a drug-in-food protocol. Food-restricted animals receive either medicated or unmedicated pellets, designed to mimic either "taking" or "missing" a drug.
Results: The system described permits the distribution of medicated or unmedicated food pellets on an experimenter-defined feeding schedule. The flexibility of this system permits the delivery of drug according to the known pharmacokinetics of investigational drugs.
Comparison with other methods: Current clinical adherence research relies on medication-event monitoring system (MEMS) tracking caps, which allows clinicians to directly monitor patient adherence. However, correlating the effects of nonadherence to efficacy still relies on the accuracy of patient journals.
Conclusion: This system allows for the design of studies to address the impact of nonadherence in an etiologically relevant animal model. Given methodological and ethical concerns of designing clinical studies of nonadherence, animal studies are critical to better understand medication adherence. While the system described was designed to measure the impact of nonadherence on seizure control, it is clear that the utility of this system extends beyond epilepsy to include other disease states.
Keywords: Anti-seizure drug; Chronic drug delivery; Drug discovery; Epilepsy; Nonadherence; Noncompliance.
Copyright © 2014 Elsevier B.V. All rights reserved.
Figures






Similar articles
-
The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy.Epilepsia. 2017 Jun;58(6):1054-1062. doi: 10.1111/epi.13742. Epub 2017 Apr 12. Epilepsia. 2017. PMID: 28401980
-
Correction of medication nonadherence results in better seizure outcomes than dose escalation in a novel preclinical epilepsy model of adherence.Epilepsia. 2019 Mar;60(3):475-484. doi: 10.1111/epi.14655. Epub 2019 Jan 22. Epilepsia. 2019. PMID: 30669183
-
Nonadherence to treatment regimens in epilepsy from the patient's perspective and predisposing factors: Differences between intentional and unintentional lack of adherence.Epilepsia. 2019 May;60(5):e58-e62. doi: 10.1111/epi.14734. Epub 2019 Apr 13. Epilepsia. 2019. PMID: 30980675
-
Insights into the novel three 'D's of epilepsy treatment: drugs, delivery systems and devices.Drug Discov Today. 2010 Sep;15(17-18):717-32. doi: 10.1016/j.drudis.2010.06.014. Epub 2010 Aug 5. Drug Discov Today. 2010. PMID: 20603226 Review.
-
Review of medication adherence in children and adults with ADHD.Postgrad Med. 2010 Jan;122(1):184-91. doi: 10.3810/pgm.2010.01.2112. Postgrad Med. 2010. PMID: 20107302 Review.
Cited by
-
Conditional Knock-out of mGluR5 from Astrocytes during Epilepsy Development Impairs High-Frequency Glutamate Uptake.J Neurosci. 2019 Jan 23;39(4):727-742. doi: 10.1523/JNEUROSCI.1148-18.2018. Epub 2018 Nov 30. J Neurosci. 2019. PMID: 30504280 Free PMC article.
-
Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital.Epilepsia. 2021 Jul;62(7):1677-1688. doi: 10.1111/epi.16955. Epub 2021 Jun 2. Epilepsia. 2021. PMID: 34080183 Free PMC article.
-
Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs.Exp Neurol. 2022 Mar;349:113954. doi: 10.1016/j.expneurol.2021.113954. Epub 2021 Dec 17. Exp Neurol. 2022. PMID: 34922908 Free PMC article.
-
Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.Neurochem Res. 2017 Jul;42(7):1873-1888. doi: 10.1007/s11064-017-2222-z. Epub 2017 Mar 13. Neurochem Res. 2017. PMID: 28290134 Review.
-
Ultrastructural and functional changes at the tripartite synapse during epileptogenesis in a model of temporal lobe epilepsy.Exp Neurol. 2020 Apr;326:113196. doi: 10.1016/j.expneurol.2020.113196. Epub 2020 Jan 11. Exp Neurol. 2020. PMID: 31935368 Free PMC article.
References
-
- Brady R, Weinman J. Adherence to cholinesterase inhibitors in Alzheimer’s disease: a review. Dement Geriatr Cogn Disord. 2013;35(5–6):351–363. - PubMed
-
- Buelow JM, Smith MC. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav. 2004;5(3):401–406. - PubMed
-
- Cramer JA, Mattson RH, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261(22):3273–3277. - PubMed
-
- Cryan JF, Mombereau C, et al. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 2005;29(4–5):571–625. - PubMed
-
- Cutler DM, Everett W. Thinking outside the pillbox--medication adherence as a priority for health care reform. N Engl J Med. 2010;362(17):1553–1555. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous